
Sign up to save your podcasts
Or


Matt, Chris, and Don discuss a new treatment for lung cancer (immunotherapy), the gang discusses a controversy that occurred when a large clinical trial decided to change its endpoint, and Chris dives into the world of linguistics (again).
Journal club article:
Pembrolizumab lung cancer trial
By Population Health Exchange4.9
125125 ratings
Matt, Chris, and Don discuss a new treatment for lung cancer (immunotherapy), the gang discusses a controversy that occurred when a large clinical trial decided to change its endpoint, and Chris dives into the world of linguistics (again).
Journal club article:
Pembrolizumab lung cancer trial

90,968 Listeners

43,972 Listeners

32,078 Listeners

38,505 Listeners

30,768 Listeners

38,771 Listeners

25,830 Listeners

87,218 Listeners

112,250 Listeners

7,215 Listeners

37 Listeners

2,080 Listeners

15,942 Listeners

2,311 Listeners

4,261 Listeners